Introduction: Laparoscopic Sleeve gastrectomy (LSG) has gained prominence as a single option for their results in terms of weight loss and improvement of comorbidities. The leakage of the staple line is an important cause of morbidity and mortality. Its management depends on the severity and clinical presentation. Our goal is to identify factors that may predispose to the occurrence of postoperative leaks. Also, describe a diagnostic/therapeutic algorithm for its management, reviewing the cases
INTRODUCTION: Laparoscopic Sleeve Gastrectomy (LSG) has gained popularity as the leading bariatric procedure for the treatment of morbid obesity. A serious complication of LSG is neuropathy, unfortunately, little is known in terms of its risk factors. Due to an increase in obesity and rising numbers of bariatric surgeries, neurologic complications have become increasingly recognized.
AIM: This study aims to examine the biochemical, hormonal, and genetic factors that are associated with neuropat
INTRODUCTION:
Obesity is a risk factor for a multitude of cancers. The underlying cause of this association is, at least partly, related to the chronic inflammatory state of obesity. GastroIntestinal Stromal Tumors(GISTs) have a reported incidence of 10-20 per million in the general population. While GISTs have not been directly associated with obesity, observed incidence is seemingly greater than the previously reported data. The purpose of this study was to determine the true incidence of GIS
OBJECTIVES: To describe the weight evolution along three years after surgery in patients undergoing Laparoscopic Sleeve Gastrectomy (LSG) and Roux-Y gastric Bypass (RYGB ) in our center.
MATERIAL AND METHODS: Retrospective review of patients treated between 2005 and 2010. Weight evolution was assessed by the following indicators: total weight (kg), body mass index and percentage of excess BMI lost (PEBMIL).
RESULTS: 297 patients (23.6%?, 76.4 % ?), mean age 46.5 years, mean weight 127.2 kg and
INTRODUCTION
In bariatric surgery, there is a lack of consensus regarding indications and methods for preoperative evaluation for Helicobacter pylori. We decided to review our current practice for H. pylori testing and create a protocol that would improve our efficiency and cost-savings. We propose that by increasing our threshold for obtaining endoscopic biopsies by using a serologic value higher than our institution’s laboratory cutoff for H. pylori seropositivity, we could avoid the need f